Skip to content

Clinical study of total laparoscopic surgery and microwave ablation in patients with colorectal cancer with liver metastases

Clinical study of total laparoscopic surgery and microwave ablation in patients with colorectal cancer with liver metastases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035844
Enrollment
Unknown
Registered
2020-08-18
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

1:Laparoscopic radical treatment of colorectal cancer + microwave ablation of liver metastases
2:Open radical treatment of colorectal cancer + liver metastasis resection

Sponsors

Ruijin Hospital North, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years old; 2. The initial diagnosis of the primary colorectal lesion was pathologically diagnosed as colorectal adenocarcinoma by endoscopic biopsy; 3. Contrast-enhanced CT and liver MRI diagnosed as liver metastasis at the first diagnosis; 4. After multidisciplinary discussion, it is expected that the primary colorectal cancer and liver metastases will be resected at the same time, and the results of R0 surgery can be obtained; 5. Preoperative ECOG physical status score 0/1; 6. Preoperative ASA score-III; 7. Patient's informed consent.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or breastfeeding; 2. Suffer from severe mental illness; 3. History of liver surgery (including interventional therapy and ablation therapy); 4. History of colorectal surgery (including ESD / EMR for colorectal cancer); 5. Preoperative imaging studies suggest extrahepatic metastasis; 6. Preoperative imaging examination revealed regional fusion and enlarged lymph nodes (maximum diameter >=3cm); 7. Preoperative imaging examination revealed portal vein tumor thrombus; 8. History of other malignant diseases within 5 years; 9. Patients with colorectal cancer who have undergone ablation, interventional treatment or recommended such treatment; 10. History of unstable angina or myocardial infarction within 6 months; 11. History of cerebral infarction or cerebral hemorrhage within 6 months; 12. A history of continuous systemic corticosteroid therapy within 1 month; 13. Concurrent surgical treatment for other diseases is required; 14. Comorbidities of colorectal cancer (bleeding, perforation, obstruction) requiring emergency surgery.

Design outcomes

Primary

MeasureTime frame
Early severe complications and operative mortality;

Secondary

MeasureTime frame
1-year DFS;1-year OS;1 year recorrent type;Early recovery process after operation;Delayed postoperative complications;

Countries

China

Contacts

Public ContactYimei Jiang

Ruijin Hospital North, Shanghai Jiaotong University School of Medicine

06crissi@sina.com+86 13818356363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026